SENSOR AUGMENTED PUMP WITH PREDICTED LOW-GLUCOSE SUSPEND FUNCTION. SHORT AND MEDIUM-TERM OUTCOMES IN YOUNG CHILDREN

被引：0
|
作者：
Prado-Carro, A. [1 ]
Sanchez-Garcia, A. M. [2 ]
Garcia-Garcia, R. [3 ]
Riano-Galan, I. [3 ]
机构：
[1] Complejo Hosp Univ A Coruna Sergas, Pediat Endocrinol & Diabet Unit, Pediat Area, La Coruna, Spain
[2] Complejo Hosp Univ A Coruna Sergas, Diabet Educ & Nutr, Pediat Area, La Coruna, Spain
[3] Hosp Univ Cent Asturias Oviedo, Unidad Endocrinol & Diabet Infantil AGC Pediat, Oviedo, Spain
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
196
引用
收藏
页码：A87 / A88
页数：2
相关论文
共 50 条
  • [1] Additional Improvement Provided by Sensor-Augmented Insulin Pump Therapy with Predictive Low-Glucose Suspend Function Compared to Low-Glucose Suspension
    Beato-Vibora, Pilar I.
    Gil-Poch, Estela
    Galan-Bueno, Laura
    Javier Arroyo-Diez, Francisco
    DIABETES, 2017, 66 : A237 - A237
  • [2] The low glucose suspend function in sensor-augmented pump therapy prevents hypoglycaemia in children
    Holder, M.
    Kordonouri, O.
    Haberland, H.
    Golembowski, S.
    Zierow, S.
    Remus, K.
    Blaesig, S.
    Wadien, T.
    Hartmann, R.
    Thomas, A.
    Danne, T.
    DIABETOLOGIA, 2011, 54 : S400 - S400
  • [3] The Low Glucose Suspend (LGS) Function in Sensor-Augmented Pump Therapy Prevents Hypoglycaemia in Children
    Danne, Thomas
    Kordonouri, Olga
    Remus, Kerstin
    Blaesig, Sara
    Holder, Martin
    Wadien, Tanja
    Haberland, Holger
    Golembowski, Sven
    Zierow, Susanne
    Hartmann, Reinhard
    Thomas, Andreas
    DIABETES, 2011, 60 : A41 - A41
  • [4] EFFICACY AND SAFETY OF SENSOR-AUGMENTED INSULIN PUMP THERAPY WITH LOW-GLUCOSE SUSPEND FEATURE IN OLDER ADULTS
    Gomez, A. M.
    Morros-Gonzalez, E.
    Borda, M. G.
    Patino-Hernandez, D.
    Perez-Zepeda, M. U.
    Marin Carrillo, L. F.
    Chavarro-Carvajal, D.
    Cano Gutierrez, C. A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A45 - A45
  • [5] Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function
    Beato-Vibora, Pilar I.
    Arroyo-Diez, Francisco J.
    ACTA DIABETOLOGICA, 2018, 55 (10) : 1083 - 1085
  • [6] Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function
    Pilar I. Beato-Víbora
    Francisco J. Arroyo-Díez
    Acta Diabetologica, 2018, 55 : 1083 - 1085
  • [7] Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes
    Isabel Beato-Vibora, Pilar
    Quiros-Lopez, Carmen
    Lazaro-Martin, Lucia
    Martin-Frias, Maria
    Barrio-Castellanos, Raquel
    Gil-Poch, Estela
    Javier Arroyo-Diez, Francisco
    Gimenez-Alvarez, Marga
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (11) : 738 - 743
  • [8] SENSOR-AUGMENTED PUMP WITH PREDICTIVE LOW GLUCOSE SUSPEND FUNCTION: IMPACT ON GLYCAEMIC CONTROL IN ADULTS AND CHILDREN
    Beato-Vibora, P. I.
    Lazaro-Martin, L.
    Quiros, C.
    Martin-Frias, M.
    Barrio-Castellanos, R.
    Gil-Poch, E.
    Arroyo-Diez, F. J.
    Gimenez, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A22 - A23
  • [9] Recommendations for the use of sensor-augmented pumps with predictive low-glucose suspend features in children: The importance of education
    Scaramuzza, Andrea E.
    Arnaldi, Claudia
    Cherubini, Valentino
    Piccinno, Elvira
    Rabbone, Ivana
    Toni, Sonia
    Tumini, Stefano
    Candela, Gilberto
    Cipriano, Paola
    Ferrito, Lucia
    Lenzi, Lorenzo
    Tinti, Davide
    Cohen, Ohad
    Lombardo, Fortunato
    PEDIATRIC DIABETES, 2017, 18 (08) : 883 - 889
  • [10] Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes
    Maria Gomez, Ana
    Marin Carrillo, Lisseth Fernanda
    Munoz Velandia, Oscar Mauricio
    Rondon Sepulveda, Martin Alonso
    Arevalo Correa, Carol M.
    Mora Garzon, Edwin
    Cuervo Diaz, Maria Camila
    Henao Carrillo, Diana Cristina
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (02) : 109 - 114
12345